The present study has demonstrated a synergistic effect of Obatoclax and Cisplatin on oral cancer cell viability and growth, indicating that elimination of anti-apoptotic Mcl-1L is crucial for chemosensitization the oral cancer cells. Here, MCL1 is linked to lip and oral cavity carcinoma.